secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001104659-24-086130
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen Q2 revenue up 76% to $2.86M; net loss narrows to $2.11M
-----------------------------------------------------------------

- Revenue $2.86M (+76% YoY); net loss $2.11M ($0.19/sh) vs $3.5M loss ($0.39/sh) in Q2 2023.
- Hired Brielan Smiechowski as SVP of Sales & Business Development.
- Next Day Quotes conversion rate 58% to purchase orders.
- Cash and securities $2.15M as of June 30, 2024, down from $5.01M at Dec 31, 2023.
- Supplier organizations reduced to 105 from 243 at year-end 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/0001104659-24-086130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/tm2420908d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-086130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer